CB50785-23 - 0x000000000000752F
Healthy Males & Females
Forward
* Stipend may pay up to reflected amount.
Start Date:
December 6, 2026 - 2:15pm
End Date:
December 21, 2026 - 8:45am
Study Details
Study Number: CB50785
Group Number: 23
Study Requirement: Healthy Normal Male and Female
Stipend: up to $6,000.00
Study Criteria
Age: 19 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 111 lbs
Study Information
Indication: This investigational medication is being developed for the treatment of multiple sclerosis (MS).
Route of Administration: Oral
Blood Draws: 34
Study Schedule
Schedule Type: Long Term
Study Length: 9 Night Stay & 2 Returns
Screening Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 11/19/2026 |
| Friday | 11/20/2026 |
| Monday | 11/23/2026 |
| Monday | 11/30/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Thursday | 11/19/2026 |
| Friday | 11/20/2026 |
| Monday | 11/23/2026 |
| Monday | 11/30/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Sunday | 12/6/2026 2:15:00 PM | Tuesday | 12/15/2026 9:45:00 AM | 1 | Lincoln |
| Return | Thursday | 12/17/2026 7:45:00 AM | Thursday | 12/17/2026 8:45:00 AM | 1 | Lincoln |
| Return | Monday | 12/21/2026 7:45:00 AM | Monday | 12/21/2026 8:45:00 AM | 1 | Lincoln |
